.png)
Advancing Clinical Research for Emerging Therapeutics
SVG Pharma is an Australian Contract Research Organisation specialising in medicinal cannabis clinical trials and selected emerging therapeutic programs. We combine scientific expertise, regulatory insight, and operational precision to support compliant clinical studies across Phase I–IV development within Australia’s regulated research environment.
FOUNDED IN 2020
GCP-ALIGNED & QUALITY-LED
AUSTRALIAN-BASED
What We Do
SVG Pharma delivers structured clinical research programs for medicinal cannabis and selected emerging therapeutics, supporting sponsors through compliant study design, execution, and reporting. Our work focuses on translating complex scientific concepts into clinically meaningful study designs aligned with ethical, regulatory, and operational requirements.
​
We support sponsors working in therapeutic areas where regulatory pathways may still be evolving, providing structured guidance and disciplined execution across the study lifecycle.
Why Choose SVG Pharma?
Specialised Therapeutic Expertise
Clinical, operational, and regulatory experience across medicinal cannabis and emerging therapeutics, supporting well-structured, ethically governed clinical studies.
Regulatory & Ethics Navigation
Practical navigation of Australian regulatory and ethics frameworks, ensuring GCP-aligned trial conduct and appropriate governance throughout study delivery.
End-To-End
Trial Delivery
Disciplined management of clinical programs from feasibility through execution and reporting, aligned to approved timelines and regulatory expectations.
Sponsor Partnership Approach
Collaborative engagement built on clear communication, transparent governance, and flexible operational models tailored to program requirements.
How We Support Sponsors
SVG Pharma delivers structured clinical research programs for medicinal cannabis and emerging therapeutics, supporting sponsors from feasibility through to study completion and reporting.
​
Our services may include:
​
Feasibility assessment and evidence pathway mapping
Regulatory and ethics strategy development
Protocol design, risk mitigation, and study planning
Trial execution, oversight, and data management
Study close-out and reporting